PRECISION QUANTOMICS INC

Biotech · Private

Pharmacogenetic testing platform using genetically diverse hepatocyte models to predict drug metabolism across polymorphic populations

Grants
$580K
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Addressing health disparities through a quantitative physiological database and precision systems modeling$294,450
Federal grantDepartment of Health and Human Services · Phase I · Recombinant human enzymes for characterization of drug metabolism in US patient populations$285,444
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2439VELOCITY LABORATORIES, LLC——
2440BRANCHPOINT BIOSCIENCES INC.——
2441SKROOT LABORATORY INC.——
2442PRECISION QUANTOMICS INC——
2443RHINO THERAPEUTICS INC——
2444INTERVAL THERAPEUTICS LLC——
2445PAZ PHARMACEUTICALS——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.